Literature DB >> 17198344

Trastuzumab-induced cardiac dysfunction.

Gurusher Singh Panjrath, Diwakar Jain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198344     DOI: 10.1097/MNM.0b013e328025ae04

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


× No keyword cloud information.
  10 in total

1.  Can serial changes of diastolic dysfunction signal incremental risk of chemotherapy-induced heart failure missed by the timing of declining LV ejection fraction?

Authors:  Ronald G Schwartz; Nicholas Venci
Journal:  J Nucl Cardiol       Date:  2015-07-24       Impact factor: 5.952

Review 2.  Cardio-oncology: the Nuclear Option.

Authors:  Jorge A Alvarez; Raymond R Russell
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

Review 3.  Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment.

Authors:  Diwakar Jain; Tauseef Ahmad; Mitchel Cairo; Wilbert Aronow
Journal:  Ann Transl Med       Date:  2017-09

Review 4.  Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.

Authors:  Diwakar Jain; Raymond R Russell; Ronald G Schwartz; Gurusher S Panjrath; Wilbert Aronow
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

Review 5.  Nuclear cardio-oncology: From its foundation to its future.

Authors:  Milan G Kahanda; Christopher A Hanson; Brandy Patterson; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-02-20       Impact factor: 5.952

6.  The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.

Authors:  Raymond R Russell; Jonathan Alexander; Diwakar Jain; Indu G Poornima; Ajay V Srivastava; Eugene Storozynsky; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2016-06-01       Impact factor: 5.952

Review 7.  Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.

Authors:  Ronald G Schwartz; Diwakar Jain; Eugene Storozynsky
Journal:  J Nucl Cardiol       Date:  2013-06       Impact factor: 5.952

Review 8.  MRI of Cardiotoxicity.

Authors:  Jennifer Hawthorne Jordan; William Gregory Hundley
Journal:  Cardiol Clin       Date:  2019-08-31       Impact factor: 2.410

9.  Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).

Authors:  Edith Pituskin; Mark Haykowsky; Margaret McNeely; John Mackey; Neil Chua; Ian Paterson
Journal:  BMC Cancer       Date:  2016-09-15       Impact factor: 4.430

Review 10.  Cardiovascular Magnetic Resonance in the Oncology Patient.

Authors:  Jennifer H Jordan; Ryan M Todd; Sujethra Vasu; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2018-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.